Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check43 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check50 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section.SummaryDifference1%
- Check64 days agoChange DetectedThe website has been updated from version 2.12.1 to 2.12.2.SummaryDifference0.0%
- Check86 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.